These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2943977)

  • 1. Use of phenytoin and carbamazepine in treatment of epilepsy.
    Ramsay RE
    Neurol Clin; 1986 Aug; 4(3):585-600. PubMed ID: 2943977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphenylhydantoin.
    Med Lett Drugs Ther; 1971 Jun; 13(12):50-1. PubMed ID: 4397721
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal.
    Gallassi R; Morreale A; Lorusso S; Procaccianti G; Lugaresi E; Baruzzi A
    Arch Neurol; 1988 Aug; 45(8):892-4. PubMed ID: 3395263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medical treatment of epilepsy: managing side effects of antiepileptic drugs.
    Livingston S; Pruce I; Pauli LL; Livingston HL
    Pediatr Ann; 1979 Apr; 8(4):261-6. PubMed ID: 156906
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbamazepine as an anticonvulsant: a pilot study.
    Troupin AS; Green JR; Levy RH
    Neurology; 1974 Sep; 24(9):863-9. PubMed ID: 4277388
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbamazepine--a double-blind comparison with phenytoin.
    Troupin A; Ojemann LM; Halpern L; Dodrill C; Wilkus R; Friel P; Feigl P
    Neurology; 1977 Jun; 27(6):511-9. PubMed ID: 405624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.
    Chadwick D; Shaw MD; Foy P; Rawlins MD; Turnbull DM
    J Neurol Neurosurg Psychiatry; 1984 Jun; 47(6):642-4. PubMed ID: 6234378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of W-554 (ADD 03055) in epileptic patients.
    Wilensky AJ; Friel PN; Ojemann LM; Kupferberg HJ; Levy RH
    Epilepsia; 1985; 26(6):602-6. PubMed ID: 4076064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin.
    Levine M; Jones MW; Sheppard I
    Neurology; 1985 Apr; 35(4):562-5. PubMed ID: 3982643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function.
    Bittencourt PR; Antoniuk SA; Bigarella MM; da Costa JC; Doro MP; Ferreira AS; Fonseca LC; Gorz AM; Gonçalves e Silva GE; Marcourakis T
    Epilepsy Res; 1993 Oct; 16(2):147-55. PubMed ID: 8269913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin and carbamazepine cross reactivity: report of a case and review of literature.
    Misra UK; Kalita J; Rathore C
    Postgrad Med J; 2003 Dec; 79(938):703-4. PubMed ID: 14707249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic toxicity of carbamazepine.
    Pisciotta AV
    Adv Neurol; 1975; 11():355-68. PubMed ID: 1217569
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monitoring plasma levels of some antiepileptic drugs (phenobarbital, diphenylhydantoin, carbamazepine) in the Lennox-Gastaut syndrome and in other forms of epilepsy (partial and secondary generalized) in childhood].
    Viani F; Gerna M; Riboldi A; Rossotti V; Morselli PL
    Riv Neurol; 1975; 45(2):189-98. PubMed ID: 809828
    [No Abstract]   [Full Text] [Related]  

  • 17. Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.
    Duncan JS; Shorvon SD; Trimble MR
    J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):924-8. PubMed ID: 3144581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three cases of carbamazepine toxicity.
    Moore NC; Lerer B; Meyendorff E; Gershon S
    Am J Psychiatry; 1985 Aug; 142(8):974-5. PubMed ID: 3161347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hydantoin intoxication: case report.
    Riley CG
    N Z Med J; 1972 Dec; 76(487):425-8. PubMed ID: 4510413
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenytoin-induced DRESS with cross-reactivity to carbamazepine in a 10-year-old Indian child.
    Mendiratta V; Bhushan P
    Clin Exp Dermatol; 2006 Sep; 31(5):720-1. PubMed ID: 16901324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.